- Ownership hops held
- 88
An absent edge means not yet observed — never does not exist.
Ovid Therapeutics Inc.
Ovid Therapeutics Inc. — US company (sec:0001636651). UBO chain traced 88 hops, 5 owners. Every claim linked to its source.
Ownership resolves 88 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Ovid Therapeutics Inc.
None in current sources.
88-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on Ovid Therapeutics Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
13 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BERNSTEIN KARENAlso holds roles at 3 other companies
- CODIAK BIOSCIENCES, INC.director
- ACHAOGEN INCdirector
- CONCURRENT PHARMACEUTICALS INCdirector
- DUNCAN BARBARA GAYLEAlso holds roles at 11 other companies
- Atea Pharmaceuticals, Inc.director
- HALOZYME THERAPEUTICS, INC.director
- FUSION PHARMACEUTICALS INC.director
- MILLENNIUM PHARMACEUTICALS INCAlso holds roles at 26 other companies
- DUNSIRE DEBORAHdirector
- BIANCHI CHRISTOPHEofficer
- DUNSIRE DEBORAHofficer
- PAPADOPOULOS STELIOSAlso holds roles at 9 other companies
- SGX PHARMACEUTICALS, INC.director
- EXELIXIS, INC.director
- Regulus Therapeutics Inc.director
- Rona Jeffrey AAlso holds roles at 2 other companies
- S&W Seed Codirector
- GREAT BASIN SCIENTIFIC, INC.officer
- TAKEDA PHARMACEUTICAL CO LTDAlso holds roles at 44 other companies
- IBRAHIM RAMY RIAD AHMEDofficer
- RICCI GABRIELEofficer
- KIM JULIE SO-YOUNGofficer
- TAKEDA PHARMACEUTICALS U.S.A., INC.Also holds roles at 4 other companies
- Day One Biopharmaceuticals, Inc.tenpercentowner
- Quince Therapeutics, Inc.tenpercentowner
- MYOVANT SCIENCES LTD.tenpercentowner
- WILLIAMS DOUGLAS EAlso holds roles at 14 other companies
- Camp4 Therapeutics Corpdirector
- ZYMOGENETICS INCofficer
- Climb Bio, Inc.director
13 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Ovid Therapeutics Inc.?
- What is Ovid Therapeutics Inc.'s risk level?
- Where does Ovid Therapeutics Inc. appear across sources?